Skip Navigation Links.
Activity Information
Presentation
Clinical Issues
Initial Labs
Additional Issues
Patient Adherence
Management Strategies
Table 1
Insulin Therapy
Management Challenges
Clinical Course
Treatment Modifications
Table 2
Clinical Course
Summary
Premixed Insulin
Selecting Insulin Therapy
Resources & References
Finish

Online CME Activity

Type 2 Diabetes Inadequately Controlled With Basal/Bolus Therapy Due to Poor Adherence

NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.

Title:
Type 2 Diabetes Inadequately Controlled With Basal/Bolus Therapy Due to Poor Adherence
Release Date:
08/03/2007
Expiration Date:
08/03/2008
Topics:
Diabetes, Metabolic Disorders
Primary Audience:
Primary Care
Activity Format:
Patient Case Study
Credits:
2.00 AMA PRA Category 1 Credits™, 2.00 AANP

 
Overall Satisfaction Rating:
Full Star Full Star Full Star Full Star Half Star 85%

Learning Objectives

Participants should be able to outline clinical approaches for initiating basal-only, basal-prandial, and premixed insulin and insulin analogs, and identify insulin therapy that best addresses the patient’s therapeutic needs.

Accreditation

This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Credits Type Accreditation Statement Designation Statement
2.00 AMA PRA Category 1 Credits™ Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
2.00 AANP Pri-Med Institute is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 2 contact hours of continuing education, which includes 1.0 hours of pharmacology.
View Additional Accreditation Information

Faculty and Editorial Board

Written By: Bernard Zinman, MD, Professor of Medicine, University of Toronto, Toronto, ON;

Reviewed By: Tufts University School of Medicine

Edited By: Jean Baker, MS, RD, Clinical Editor, Pri-Med Institute, Boston, MA;

Financial Disclosure Statement(s)

Dr Zinman receives honoraria as a Scientific Advisory Board Member for Eli Lilly and Company, Novo Nordisk Inc., and sanofi-aventis U.S. and research grant funding from Eli Lilly and Company and Novo Nordisk Inc.
Ms Baker has no financial relationships to disclose.
The content collaborators at International Medical Press have no financial relationships to disclose.

Education Partner:

International Medical Press

Commercial Support:

Eli Lilly & Company

Instructions for Obtaining Credit:

Complete this activity. Answer the questions in the attached evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.

Computer System Requirements:

Internet Explorer (version 5.5 and above) is the recommended browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies. If cookies are disabled, the site may not function properly. A minimum screen resolution setting of 800 x 600 is recommended. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.